Biotech Breakdown: Market Rallies, Biotechs Don't (10/9/15)

Market Analysis

  • S&P should eventually make it to 2050 +/-
  • DOW channel resistance sits near 17300
  • Nasdaq underperforming noticeably

Biotech

  • IBB sits just under its upper trendline. A push above 310 would be positive
  • ICPT broke above 180, should run at 200
  • VRX cleared the 170, should make it to 180
  • ILMN stuck between 140 and 150
  • KITE back near 66
  • INCY held 100
  • REGN testing 500
Posted to The Biotech Trader on Oct 09, 2015 — 10:10 AM
Comments ({[comments.length]})
Sort By:
Loading Comments
No comments. Break the ice and be the first!
Error loading comments Click here to retry
No comments found matching this filter
Want to add a comment? Take me to the new comment box!